Patents by Inventor Mike Looker

Mike Looker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8372654
    Abstract: The invention is concerned with Nuclear Magnetic Resonance (NMR) spectroscopy and Magnetic Resonance Imaging (MRI), particularly NMR spectroscopy. It provides hyperpolarization methods offering enhanced sensitivity of detection over conventional NMR for studying the fate of a test compound in a biological system. The methods are particularly suitable for studying metabolism and toxicity of drugs. The resulting NMR sensitivity increase is advantageous in two key aspects of NMR detection: test compounds can be detected at lower concentrations and substantial time saving can be achieved in cases where extensive averaging is conventionally employed to increase the signal to noise ratio of the corresponding NMR spectra. The methods can be used for studios that were not practical or not possible using conventional NMR.
    Type: Grant
    Filed: June 12, 2001
    Date of Patent: February 12, 2013
    Assignee: GE Healthcare Limited
    Inventors: Neil Cook, Albie Santos, Nigel Bosworth, Jan Wolber, Mike Looker, Peter Knox, Jan Jenrik Ardenkjaer-Larsen, Klaes Golman
  • Publication number: 20050232864
    Abstract: The invention relates to methods for phenotyping by determining protein activity in vivo using at least one probe compound and enhancing the nuclear polarisation of NMR active nuclei present in the probe compound (hereinafter termed “hyperpolarisation”) prior to NMR analysis.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 20, 2005
    Inventors: Bill Clark, Klaes Golman, Mathilde Lerche, Mike Looker, Mike O'Sullivan, Albie Santos, Rolf Servin, Mikkel Thaning, Jan-Henrik Ardenkjaer-Larsen
  • Publication number: 20050233470
    Abstract: The invention relates to methods for determining protein activity using NMR spectroscopy. The present invention provides a method for determining protein activity in vivo using probe compounds and enhancing the nuclear polarisation of NMR active nuclei present in the probe compounds (hereinafter termed “hyperpolarisation”) prior to NMR analysis. The invention also provides mixtures of probe compounds for the above-mentioned method.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 20, 2005
    Inventors: Bill Clark, Klaes Golman, Mathilde Lerche, Mike Looker, Mike O'Sullivan, Albie Santos, Rolf Servin, Mikkel Thaning, Jan-Henrik Ardenkjaer-Larsen
  • Publication number: 20040039281
    Abstract: The invention is concerned with Nuclear Magnetic Resonance (NMR) spectroscopy and Magnetic Resonance Imaging (MRI), particularly NMR spectroscopy. It provides hyperpolarisation methods offering enhanced sensitivity of detection over conventional NMR for studying the fate of a test compound in a biological system. The methods are particularly suitable for studying metabolism and toxicity of drugs. The resulting NMR sensitivity increase is advantageous in two key aspects of NMR detection: test compounds can be detected at lower concentrations and substantial time saving can be achieved in cases where extensive averaging is conventionaly employed to increase the signal to noise ratio of the corresponding NMR spectra. The methods can be used for studios that were not practical or not possible using conventional NMR.
    Type: Application
    Filed: July 17, 2003
    Publication date: February 26, 2004
    Inventors: Neil Cook, Albie Santos, Nigel Bosworth, Jan Wolber, Mike Looker, Peter Knox, Jan Jenrik Ardenkjaer-Larsen, Klaes Golman